Casirivimab and Imdevimab Injection, 2400 mg

Name: Negotiated commercial rates for Casirivimab and Imdevimab Injection, 2400 mg (HCPCS Q0243), in Pennsylvania
Creator: Tynbil
License: https://tynbil.com/terms

Pennsylvania rates for HCPCS Q0243

Injection, casirivimab and imdevimab, 2400 mg

Rates data updated July 2026.

Rates by insurance carrier

Insurance Carrier	Facility/Professional	Modifier	Typical Low	Median	Typical High